Cardiovascular Safety of Prostate Cancer Treatments Still Undecided
September 13th 2021New research has found that the relative cardiovascular safety of different types of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the PRONOUNCE trial was terminated early.
Read More
Pharmacists Can Help Treat Post-Intensive Care Syndrome
Managing transitions of care is vital to discontinue use of unnecessary drugs and minimize medication errors.
Read More
Pharmacy Focus Podcast: New Series - Move the Needle Monday
September 13th 2021The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Listen
Expert: FDA to Continue Efforts to Address Disparities in Cancer Drug Trials
September 10th 2021Lola Fashoyin-Aje, MD, MPH, associate director of Science & Policy Program to Address Disparities at the FDA’s Oncology Center of Excellence, discusses the importance of promoting inclusion of members of racial and ethnic minority groups in cancer drug trials.
Watch